Autologous Hematopoietic Stem Cell Transplantation for Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Josée Masson-Roy(Université Laval), Pierre R. Bourque(University of Ottawa), Jodi Warman‐Chardon(University of Ottawa), Christopher Bredeson, Lisa Martin(Canadian Blood Services), Natasha Kekre(Ottawa Hospital), Harold Atkins(University of Ottawa), Sheryl McDiarmid(Ottawa Hospital), Sultan Altouri(Ottawa Hospital), Ari Breiner(University of Ottawa), Lothar Huebsch(University of Ottawa), Michael Kennah, David Allan(University of Ottawa), C. Elizabeth Pringle(University of Ottawa)
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
February 26, 2021
Cited by 13
Related Papers
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
|Cancer Cell|2003|850
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
|Nature Medicine|2000|816
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
|New England Journal of Medicine|2018|598
A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)
|Journal of Computer Assisted Tomography|1980|503
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442